Journal article
A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
Abstract
BACKGROUND: The efficacy and safety of thromboprophylaxis in patients with acute medical illnesses who may be at risk for venous thromboembolism have not been determined in adequately designed trials.
METHODS: In a double-blind study, we randomly assigned 1102 hospitalized patients older than 40 years to receive 40 mg of enoxaparin, 20 mg of enoxaparin, or placebo subcutaneously once daily for 6 to 14 days. Most patients were not in an …
Authors
Samama MM; Cohen AT; Darmon J-Y; Desjardins L; Eldor A; Janbon C; Leizorovicz A; Nguyen H; Olsson C-G; Turpie AG
Journal
New England Journal of Medicine, Vol. 341, No. 11, pp. 793–800
Publisher
Massachusetts Medical Society
Publication Date
September 9, 1999
DOI
10.1056/nejm199909093411103
ISSN
0028-4793